TNF and hepatosplenic T-cell lymphoma: The most concerning long-term adverse event associated with TNF-a inhibitors is the development of hepatosplenic T cell lymphoma (HSTCL); however, it must be noted that in each reported case the patient was also being treated with thiopurines [21].